Skip to content

Novavax

US · NVAX #2865 by market cap Listed 1970
7.47 -0.25 -3.24%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Company notice
    Novavax | 8-K: Current report
    SEC · 2026/10/30
  • B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy Rating
    MT Newswires · 2026/11/6
  • Rating change
    BofA Adjusts Price Target on Novavax to $8 From $7, Keeps Underperform Rating
    MT Newswires · 2026/10/9
  • Rating change
    Citi Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $8
    Market Newswire · 2026/10/15
  • Company notice
    Novavax | 10-Q: Quarterly report
    SEC · 2026/11/5
  • B. Riley Securities Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $16
    Market Newswire · 2026/11/7
  • Company notice
    Novavax | SCHEDULE 13G: Others
    SEC · 2026/10/17
  • Rating change
    Citigroup Maintains Sell on Novavax, Raises Price Target to $8
    Benzinga · 2026/10/16
  • Rating change
    Novavax Is Maintained at Sell by Citigroup
    Dow Jones · 2026/10/16
  • Rating change
    Cantor Fitzgerald Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $18
    Market Newswire · 2026/10/27
  • Novavax to Participate in Jefferies London Healthcare Conference
    PR Newswire · 2026/11/12
  • Rating change
    Bank of America Securities Remains a Sell on Novavax (NVAX)
    TipRanks · 2026/10/23
  • BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Cuts Target Price to $7
    Market Newswire · 2026/11/6
  • Rating change
    BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $8
    Market Newswire · 2026/10/9
  • Rating change
    Citi Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8
    Market Newswire · 2026/10/16
  • These Analysts Just Made A Huge Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
    Simply Wall St · 2026/11/12
  • Company notice
    Novavax | 8-K: Novavax Reports Third Quarter 2026 Financial Results and Operational Highlights
    SEC · 2026/11/5
  • Rating change
    Novavax Price Target Raised to $8.00/Share From $7.00 by Citigroup
    Dow Jones · 2026/10/16
  • Rating change
    BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8
    Market Newswire · 2026/10/23
  • Company notice
    Novavax | SCHEDULE 13G: Others
    SEC · 2026/11/10
  • Rating change
    Cantor Fitzgerald Sticks to Its Buy Rating for Novavax (NVAX)
    TipRanks · 2026/8/7
  • Novavax Halts Omicron Booster Study, Raising Fresh Questions for NVAX Investors
    TipRanks · 2026/10/24
  • Company notice
    Novavax | SCHEDULE 13G: Others
    SEC · 2026/8/7
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP), Ultragenyx Pharmaceutical (RARE) and Novavax (NVAX)
    TipRanks · 2026/9/21
  • Earnings Preview: Novavax to Report Financial Results Pre-market on November 05
    Market Newswire · 2026/10/31

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:36 · For reference only, not investment advice and not tailored to your situation.

Novavax discussion 0 comments

Add a comment